Weitz & Luxenberg is no longer taking Digitek cases
Activis issues recall of heart med Digitek (digoxin)
Get a free legal review of your potential case when you complete the form below.
FDA Digitek Recall: On April 25, 2008, Actavis Totowa LLC, issued the following release to announce a Class 1 recall of the drug Digitek, a drug prescribed to treat conditions such as congestive heart failure and and atrial fibrillation/atrial flutter (types of fast heartbeats).
Actavis Totowa (formerly known as Amide Pharmaceutical, Inc.) recalls all lots of Bertek and UDL Laboratories Digitek® (digoxin tablets, USP) as precautionContact:
Stericycle customer service
1-888-276-6166
DIGITEK RECALL: FOR IMMEDIATE RELEASE -- Morristown, NJ -- April 25, 2008 -- Actavis Totowa LLC, a United States manufacturing division of the international generic pharmaceutical company Actavis Group, is initiating a Class I nationwide recall of Digitek® (digoxin tablets, USP, all strengths) for oral use. The products are distributed by Mylan Pharmaceuticals Inc., under a "Bertek" label and by UDL Laboratories, Inc. under a "UDL" label.
The voluntary all lot Digitek recall is due to the possibility that tablets with double the appropriate thickness may have been commercially released. These tablets may contain twice the approved level of active ingredient than it appropriate.
Digitek® is used to treat heart failure and abnormal heart rhythms. The existence of double strength tablets poses a risk of digitalis toxicity in patients with renal failure. Digitalis toxicity can cause nausea, vomiting, dizziness, low blood pressure, cardiac instability and bradycardia. Death can also result from excessive Digitalis intake. Several reports of illnesses and injuries have been received.
Actavis manufactures the products for Mylan and the products are distributed by Mylan and UDL under the Bertek and UDL labels. Bertek and UDL are affiliates of Mylan.
Any customer inquiries related to this Digitek recall should be addressed to Stericycle customer service at 1-888-276-6166 with representatives available Monday through Friday, 8 am to 5 pm EST. Additional information about the voluntary Digitek recall can also be found at www.actavis.us.
Retailers who have this product are urged to return the product to their place of purchase. If consumers have medical questions about this Digitek recall, they should contact their health care providers. This recall is being conducted with the knowledge of the Food and Drug Administration. Any adverse reactions experienced with the use of this product, and/or quality problems should also be reported to the FDA's MedWatch Program by phone at 1-800-FDA-1088, by Fax at 1-800-FDA-0178, by mail at MedWatch, FDA, 5600 Fishers Lane, Rockville, MD 20852-9787, or on the MedWatch website at www.fda.gov/medwatch.
The above Digitek recall release can also be found at the FDA website.
Numerous people are coming forward to say the death of a loved one was caused by defective Digitek tablets. If you have been harmed by Digitek, please complete the form below for a complementary review your potential case.
see also:
Digitek Dosage
Digitek Recall Due to Some Double-Strength Dosages--possible lawsuitsAttorneys: We are reviewing possible case from Digitek overdosage
digitek lawsuit
Lawyers Review Possible Digitek and Raptiva Lawsuits. Free Case ReviewHave your Digitek or Raptiva lawsuit reviewed by our drug attorneys.
Digitek Recall
FDA: Digitek Recall Due to Some Double Doses--Free Lawsuit ReviewSearching for lawsuit information on Digitek recall? Digitek Lawyers
